Egle Tamulevičiūtė-Prascienė1, Aurelija Beigienė2, Mark James Thompson3, Kristina Balnė4, Raimondas Kubilius2, Birna Bjarnason-Wehrens5. 1. Rehabilitation Department, Lithuanian University of Health Sciences, Eiveniu g. 2, LT-50161, Kaunas, Lithuania. egle.tamuleviciute-prasciene@lsmuni.lt. 2. Rehabilitation Department, Lithuanian University of Health Sciences, Eiveniu g. 2, LT-50161, Kaunas, Lithuania. 3. University of Zurich, Rämistrasse 71, CH-8006, Zürich, Switzerland. 4. Faculty of Medicine, Lithuanian University of Health Sciences, A. Mickevičiaus g. 9, LT-44307, Kaunas, Lithuania. 5. Institute of Cardiology and Sports Medicine, Department of Preventive and Rehabilitative Sport and Exercise Medicine, German Sport University Cologne, Am Sportpark Muengersdorf 6, 50933, Cologne, Germany.
Abstract
BACKGROUND: To evaluate the short- and mid-term effect of a specially tailored resistance and balance training provided in addition to usual cardiac rehabilitation (CR) care program in older patients after valve surgery/intervention. METHODS: Single-center (inpatient CR clinic in Lithuania) randomized controlled trial. Two hundred fifty-two patients were assessed for eligibility on the first day of admittance to CR early after (14.5 ± 5.9 days) valve surgery/intervention between January 2018 and November 2019. Participants were coded centrally in accordance with randomization 1:1 using a computerized list. Control group (CG) patients were provided with usual care phase-II-CR inpatient multidisciplinary CR program, while intervention group (IG) patients received additional resistance and balance training (3 d/wk). Patients participated in a 3-month follow-up. Main outcome measures were functional capacity (6 min walk test (6MWT, meters), cardiopulmonary exercise testing), physical performance (Short Physical Performance Battery (SPPB, score) and 5-m walk test (5MWT, meters/second)), strength (one repetition maximum test for leg press), physical frailty (SPPB, 5MWT). RESULTS: One hundred sixteen patients (76.1 ± 6.7 years, 50% male) who fulfilled the study inclusion criteria were randomized to IG (n = 60) or CG (n = 56) and participated in CR (18.6 ± 2.7 days). As a result, 6MWT (IG 247 ± 94.1 vs. 348 ± 100.1, CG 232 ± 102.8 vs. 333 ± 120.7), SPPB (IG 8.31 ± 2.21 vs. 9.51 ± 2.24, CG 7.95 ± 2.01 vs. 9.08 ± 2.35), 5MWT (IG 0.847 ± 0.31 vs. 0.965 ± 0.3, CG 0.765 ± 0.24 vs 0.879 ± 0.29) all other outcome variables and physical frailty level improved significantly (p < 0.05) in both groups with no significant difference between groups. Improvements were sustained over the 3-month follow-up for 6MWT (IG 348 ± 113 vs. CG 332 ± 147.4), SPPB (IG 10.37 ± 1.59 vs CG 9.44 ± 2.34), 5MWT (IG 1.086 ± 0. 307 vs CG 1.123 ± 0.539) and other variables. Improvement in physical frailty level was significantly more pronounced in IG (p < 0.05) after the 3-month follow-up. CONCLUSION: Exercise-based CR improves functional and exercise capacity, physical performance, and muscular strength, and reduces physical frailty levels in patients after valve surgery/intervention in the short and medium terms. SPPB score and 5MWT were useful for physical frailty assessment, screening and evaluation of outcomes in a CR setting. Additional benefit from the resistance and balance training could not be confirmed. TRIAL REGISTRATION: NCT04234087 , retrospectively registered 21 January 2020.
BACKGROUND: To evaluate the short- and mid-term effect of a specially tailored resistance and balance training provided in addition to usual cardiac rehabilitation (CR) care program in older patients after valve surgery/intervention. METHODS: Single-center (inpatient CR clinic in Lithuania) randomized controlled trial. Two hundred fifty-two patients were assessed for eligibility on the first day of admittance to CR early after (14.5 ± 5.9 days) valve surgery/intervention between January 2018 and November 2019. Participants were coded centrally in accordance with randomization 1:1 using a computerized list. Control group (CG) patients were provided with usual care phase-II-CR inpatient multidisciplinary CR program, while intervention group (IG) patients received additional resistance and balance training (3 d/wk). Patients participated in a 3-month follow-up. Main outcome measures were functional capacity (6 min walk test (6MWT, meters), cardiopulmonary exercise testing), physical performance (Short Physical Performance Battery (SPPB, score) and 5-m walk test (5MWT, meters/second)), strength (one repetition maximum test for leg press), physical frailty (SPPB, 5MWT). RESULTS: One hundred sixteen patients (76.1 ± 6.7 years, 50% male) who fulfilled the study inclusion criteria were randomized to IG (n = 60) or CG (n = 56) and participated in CR (18.6 ± 2.7 days). As a result, 6MWT (IG 247 ± 94.1 vs. 348 ± 100.1, CG 232 ± 102.8 vs. 333 ± 120.7), SPPB (IG 8.31 ± 2.21 vs. 9.51 ± 2.24, CG 7.95 ± 2.01 vs. 9.08 ± 2.35), 5MWT (IG 0.847 ± 0.31 vs. 0.965 ± 0.3, CG 0.765 ± 0.24 vs 0.879 ± 0.29) all other outcome variables and physical frailty level improved significantly (p < 0.05) in both groups with no significant difference between groups. Improvements were sustained over the 3-month follow-up for 6MWT (IG 348 ± 113 vs. CG 332 ± 147.4), SPPB (IG 10.37 ± 1.59 vs CG 9.44 ± 2.34), 5MWT (IG 1.086 ± 0. 307 vs CG 1.123 ± 0.539) and other variables. Improvement in physical frailty level was significantly more pronounced in IG (p < 0.05) after the 3-month follow-up. CONCLUSION: Exercise-based CR improves functional and exercise capacity, physical performance, and muscular strength, and reduces physical frailty levels in patients after valve surgery/intervention in the short and medium terms. SPPB score and 5MWT were useful for physical frailty assessment, screening and evaluation of outcomes in a CR setting. Additional benefit from the resistance and balance training could not be confirmed. TRIAL REGISTRATION: NCT04234087 , retrospectively registered 21 January 2020.
Entities:
Keywords:
Cardiac rehabilitation; Exercise training; Physical frailty; TAVI; Valve surgery
Authors: Axel Pressler; Jeffrey W Christle; Benjamin Lechner; Viola Grabs; Bernhard Haller; Ina Hettich; David Jochheim; Julinda Mehilli; Rüdiger Lange; Sabine Bleiziffer; Martin Halle Journal: Am Heart J Date: 2016-08-26 Impact factor: 4.749
Authors: Stephanie Studenski; Subashan Perera; Kushang Patel; Caterina Rosano; Kimberly Faulkner; Marco Inzitari; Jennifer Brach; Julie Chandler; Peggy Cawthon; Elizabeth Barrett Connor; Michael Nevitt; Marjolein Visser; Stephen Kritchevsky; Stefania Badinelli; Tamara Harris; Anne B Newman; Jane Cauley; Luigi Ferrucci; Jack Guralnik Journal: JAMA Date: 2011-01-05 Impact factor: 56.272
Authors: Cristiana Vitale; Ewa Jankowska; Loreena Hill; Massimo Piepoli; Wolfram Doehner; Stefan D Anker; Mitja Lainscak; Tiny Jaarsma; Piotr Ponikowski; Giuseppe M C Rosano; Petar Seferovic; Andrew J Coats Journal: Eur J Heart Fail Date: 2019-10-23 Impact factor: 15.534
Authors: Axel Pressler; Leonie Förschner; Jana Hummel; Bernhard Haller; Jeffrey W Christle; Martin Halle Journal: Eur J Prev Cardiol Date: 2018-03-19 Impact factor: 7.804
Authors: Marco Ambrosetti; Ana Abreu; Ugo Corrà; Constantinos H Davos; Dominique Hansen; Ines Frederix; Marie C Iliou; Roberto Fe Pedretti; Jean-Paul Schmid; Carlo Vigorito; Heinz Voller; Matthias Wilhelm; Massimo F Piepoli; Birna Bjarnason-Wehrens; Thomas Berger; Alain Cohen-Solal; Veronique Cornelissen; Paul Dendale; Wolfram Doehner; Dan Gaita; Andreas B Gevaert; Hareld Kemps; Nicolle Kraenkel; Jari Laukkanen; Miguel Mendes; Josef Niebauer; Maria Simonenko; Ann-Dorthe Olsen Zwisler Journal: Eur J Prev Cardiol Date: 2020-04-07 Impact factor: 7.804
Authors: Sarah Eichler; Annett Salzwedel; Axel Harnath; Christian Butter; Karl Wegscheider; Mihai Chiorean; Heinz Völler; Rona Reibis Journal: Clin Res Cardiol Date: 2017-11-21 Impact factor: 5.460
Authors: Naila Ijaz; Brian Buta; Qian-Li Xue; Denise T Mohess; Archana Bushan; Henry Tran; Wayne Batchelor; Christopher R deFilippi; Jeremy D Walston; Karen Bandeen-Roche; Daniel E Forman; Jon R Resar; Christopher M O'Connor; Gary Gerstenblith; Abdulla A Damluji Journal: J Am Coll Cardiol Date: 2022-02-08 Impact factor: 24.094